Senti Biosciences Inc (SNTI) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.32 (+2.17%), Market cap $0.03B, 52-week low–high $0.77 ~ $3.84.
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. It offers SENTI-202, a logic gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers and relapsed/refractory hematological malignancies, including acute myeloid leukemia. In addition, the company develops the tumor-associated antigen and protectiv
Financial statements, price targets, institutional (13F) holdings and related news for Senti Biosciences Inc are updated in real time on BlackAll Trade.
Senti Biosciences Inc trades at $0.32 (+2.17%). Real-time quotes and charts are available on BlackAll Trade.
Senti Biosciences Inc has a market cap of about $0.03B.
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable dis